tiprankstipranks
Trending News
More News >
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
21d ago
Cautious Stance on LAVA Therapeutics Amid Strategic Review and Workforce Reduction
Premium
Ratings
Cautious Stance on LAVA Therapeutics Amid Strategic Review and Workforce Reduction
1M ago
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
LAVA Therapeutics to Transition to U.S. Domestic Issuer
PremiumCompany AnnouncementsLAVA Therapeutics to Transition to U.S. Domestic Issuer
3M ago
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
Premium
The Fly
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
4M ago
Lava Therapeutics downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Lava Therapeutics downgraded to Market Perform from Outperform at Leerink
4M ago
LAVA Therapeutics Faces Financial Hurdles
PremiumCompany AnnouncementsLAVA Therapeutics Faces Financial Hurdles
8M ago
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
Premium
The Fly
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
8M ago
Is LVTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is LVTX a Buy, Before Earnings?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100